Nurix Therapeutics Inc (NRIX) saw an uptrend of 544731% in the recent trading with $987060.0 being its most recent. The current price level -59.47% lower than the highest price of $29.56 marked by the stock while trading over the past 52-weeks, whereas it is 46.45% higher than the lowest price of $8.18 the company dropped to over past 52-weeks. The latest news story on NRIX appeared in (Zacks) under the title “Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates” on Jun-17-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 16 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.33 for the stock.
Nurix Therapeutics Inc Earnings – What Happened With NRIX
Coming around sales and income figures on NRIX Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Nurix Therapeutics Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 76.23 million. NRIX does have institutional investors; and they hold 110.63% of the stock.
As on 2024-06-30, BLACKROCK INC. was the top most holder in Nurix Therapeutics Inc (NASDAQ:NRIX) with an ownership of 6.82 million shares of the company or 10.9334 of the stake worth $142.33 million. The filing also reveals REDMILE GROUP, LLC as the second largest holder in the company with a control over 7.0917 of the outstanding shares. Its stake is worth $92.32 million for having 4.42 million shares in hand.
DEEP TRACK CAPITAL, LP also came holding a key position in the company during the recent quarter and it now holds 6.3989 of the outstanding shares. With this there are now 245.0 institutions which have possession in NRIX’s shares.
Key Metrics forNRIX
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Nurix Therapeutics Inc has a debt to equity ratio of 0.06.
Technical Analysis of Nurix Therapeutics Inc (NASDAQ:NRIX) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Nurix Therapeutics Inc (NRIX), we notice that the stock’s 20-day average volume is at 852,855 shares. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 881,542 shares. And to end, NRIX’s 100-day average volume is 911,000 shares with 100% of the long-term indicators pointing towards Sell for the stock.
